RxDoctor Payments DataLook up a doctor →

Sigurd Berven, MD

Orthopaedic Surgery · San Francisco, CANPI 1336193812

Payments from drug & device makers

$4,073,660in general payments, 2019–2025

Across 671 payments — averaging $6071.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2.3M
  • Stryker$1.3M
  • Depuy Synthes Products, Inc.$103K
  • Globus Medical$81K
  • Kyocera Medical Technologies, Inc.$53K
  • Integrity Implants Inc.$47K
  • plus $219K from 47 others
$9,750in research payments, 2019–2025

Across 9 payments — averaging $1083.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$10K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,073,660 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$261,704
Medicare patients
102
Services billed
510

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →